AUPM296493A0 - Immunoreactive antigens of hepatitis e virus - II - Google Patents

Immunoreactive antigens of hepatitis e virus - II

Info

Publication number
AUPM296493A0
AUPM296493A0 AUPM2964A AUPM296493A AUPM296493A0 AU PM296493 A0 AUPM296493 A0 AU PM296493A0 AU PM2964 A AUPM2964 A AU PM2964A AU PM296493 A AUPM296493 A AU PM296493A AU PM296493 A0 AUPM296493 A0 AU PM296493A0
Authority
AU
Australia
Prior art keywords
hepatitis
virus
immunoreactive antigens
immunoreactive
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPM2964A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FAIRFIELD HOSPITAL
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Original Assignee
FAIRFIELD HOSPITAL
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FAIRFIELD HOSPITAL, Macfarlane Burnet Institute for Medical Research and Public Health Ltd filed Critical FAIRFIELD HOSPITAL
Priority to AUPM2964A priority Critical patent/AUPM296493A0/en
Publication of AUPM296493A0 publication Critical patent/AUPM296493A0/en
Priority to JP7509443A priority patent/JPH09503912A/en
Priority to CA002170521A priority patent/CA2170521A1/en
Priority to PCT/AU1994/000572 priority patent/WO1995008632A1/en
Priority to AU77348/94A priority patent/AU694139B2/en
Priority to SG9603309A priority patent/SG95574A1/en
Priority to AT94928211T priority patent/ATE382696T1/en
Priority to EP94928211A priority patent/EP0722499B1/en
Priority to DE69435059T priority patent/DE69435059D1/en
Priority to US09/172,699 priority patent/US6514690B1/en
Abandoned legal-status Critical Current

Links

AUPM2964A 1993-09-23 1993-12-15 Immunoreactive antigens of hepatitis e virus - II Abandoned AUPM296493A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPM2964A AUPM296493A0 (en) 1993-12-15 1993-12-15 Immunoreactive antigens of hepatitis e virus - II
DE69435059T DE69435059D1 (en) 1993-09-24 1994-09-23 IMMUNOREACTIVE ANTIGENES OF HEPATITIS E VIRUSES
AU77348/94A AU694139B2 (en) 1993-09-24 1994-09-23 Immunoreactive antigens of hepatitis E virus
CA002170521A CA2170521A1 (en) 1993-09-24 1994-09-23 Immunoreactive antigens of hepatitis e virus
PCT/AU1994/000572 WO1995008632A1 (en) 1993-09-24 1994-09-23 Immunoreactive antigens of hepatitis e virus
JP7509443A JPH09503912A (en) 1993-09-24 1994-09-23 Immunoreactive antigen of hepatitis E virus
SG9603309A SG95574A1 (en) 1993-09-24 1994-09-23 Immunoreactive antigens of hepatitia e virus
AT94928211T ATE382696T1 (en) 1993-09-24 1994-09-23 IMMUNOREACTIVE ANTIGENS OF THE HEPATITIS E VIRUSE
EP94928211A EP0722499B1 (en) 1993-09-24 1994-09-23 Immunoreactive antigens of hepatitis e virus
US09/172,699 US6514690B1 (en) 1993-09-23 1998-10-14 Immunoreactive antigens of Hepatitis E Virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM2964A AUPM296493A0 (en) 1993-12-15 1993-12-15 Immunoreactive antigens of hepatitis e virus - II

Publications (1)

Publication Number Publication Date
AUPM296493A0 true AUPM296493A0 (en) 1994-01-13

Family

ID=3777590

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPM2964A Abandoned AUPM296493A0 (en) 1993-09-23 1993-12-15 Immunoreactive antigens of hepatitis e virus - II

Country Status (1)

Country Link
AU (1) AUPM296493A0 (en)

Similar Documents

Publication Publication Date Title
AU6304996A (en) Vaccines against hepatitis c
AU5926994A (en) Surface modified lens
AU4878096A (en) Hepatitis b vaccine
AU7991491A (en) Highly reflective biogratings and method
AU6774294A (en) Methods of preventing viral replication
AU3459593A (en) Humanised antibody against hepatitis
AU9111991A (en) Preparation of foam-in-fabric articles
IL108176A0 (en) Preparation of alkyl 2-alkyl-4-fluoromethyl-thiazolecarboxylates
AU6723294A (en) Use of simmondsine
PL306204A1 (en) Novel derivatives of imidazopyrimidine
AU5049296A (en) Novel epicholesterol dehydrogenase
AU5425194A (en) Detection of anti-hpa antibodies
ZA944577B (en) Preparation of aminopropionitriles
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
AUPM296493A0 (en) Immunoreactive antigens of hepatitis e virus - II
AU6852994A (en) Saucepan
GB2275266A8 (en) Preparation of 2-methyl-3-aminobenzotrifluoride
AU6991098A (en) Immunoreactive antigens of hepatitis E virus
ZA947564B (en) Production of antigens
AU7862291A (en) Modified antibodies
AU6977894A (en) Storage of antibodies
ZA94740B (en) Expression of pretective antigens
RU2003311C1 (en) Method of blepharorrhaphy
AU631340B2 (en) Copolyester
SG70973A1 (en) Preparation of co-polymers